BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Dolat Capital Report
Dabur India Ltd.'s Q1 FY21 revenues came in line, while Ebitda and adjusted profit after tax missed our estimate.
Domestic FMCG volumes declined by 9.7% YoY. Though sales were significantly down in the beginning of the quarter, most of the categories witnessed gradual recovery by the end of June.
Healthcare contribution grew from 27% in Q1 FY20 to 38% in Q1 FY21 led by 7 times growth in Chyawanprash and 60% growth in Honey—indicates change in consumer preferences.
We believe that the healthcare category would continue to grow faster post Covid-19 with new launches.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the brokerage and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
As a Subscriber you get
Stories
RECOMMENDED FOR YOU
POPULAR